BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10517070)

  • 1. Colorectal cancer surveillance in African-American and white patients at an urban university medical center.
    Borum ML
    J Natl Med Assoc; 1999 Sep; 91(9):505-8. PubMed ID: 10517070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer screening in women by internal medicine resident physicians.
    Borum ML
    South Med J; 1997 Nov; 90(11):1101-5. PubMed ID: 9386051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening of African Americans by internal medicine resident physicians can be improved with focused educational efforts.
    Friedman M; Borum ML
    J Natl Med Assoc; 2007 Sep; 99(9):1010-2. PubMed ID: 17913110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical residents' colorectal cancer screening may be dependent on ambulatory care education.
    Borum ML
    Dig Dis Sci; 1997 Jun; 42(6):1176-8. PubMed ID: 9201080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening among African-American and white male veterans.
    Dolan NC; Ferreira MR; Fitzgibbon ML; Davis TC; Rademaker AW; Liu D; Lee J; Wolf M; Schmitt BP; Bennett CL
    Am J Prev Med; 2005 Jun; 28(5):479-82. PubMed ID: 15894152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening by obstetrician-gynecologists.
    Musinski SE
    Am J Obstet Gynecol; 2001 May; 184(6):1054-6. PubMed ID: 11349154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Holme Ø; Bretthauer M; Fretheim A; Odgaard-Jensen J; Hoff G
    Cochrane Database Syst Rev; 2013 Oct; 2013(9):CD009259. PubMed ID: 24085634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer incidence in pattern and model makers: evidence from a screening program.
    Demers RY; Parsons KC
    Am J Ind Med; 1994 Jul; 26(1):33-45. PubMed ID: 8074123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of fecal hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening.
    Bang KM; Tillett S; Hoar SK; Blair A; McDougall V
    J Occup Med; 1986 Aug; 28(8):709-13. PubMed ID: 3746495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases.
    Erkek B; Ozkan N; Bayar S; Genc V; Ekrem U; Kuzu A; Aribal D
    Hepatogastroenterology; 2007; 54(73):77-80. PubMed ID: 17419235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S.
    Coughlin SS; Thompson TD; Seeff L; Richards T; Stallings F
    Cancer; 2002 Nov; 95(10):2211-22. PubMed ID: 12412176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education improves colorectal cancer screening by flexible sigmoidoscopy in an inner city population.
    Zubarik R; Eisen G; Zubarik J; Teal C; Benjamin S; Glaser M; Jack M
    Am J Gastroenterol; 2000 Feb; 95(2):509-12. PubMed ID: 10685759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood.
    Rumans MC; Benner KG; Keeffe EB; Custis JM; Lockwood DR; Craner GE
    West J Med; 1986 Jun; 144(6):756-8. PubMed ID: 3088841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia.
    Rozen P; Ron E; Fireman Z; Hallak A; Grossman A; Baratz M; Rattan J; Gilat T
    Cancer; 1987 Nov; 60(10):2553-8. PubMed ID: 3664435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does age influence screening for colorectal cancer?
    Borum ML
    Age Ageing; 1998 Jul; 27(4):509-11. PubMed ID: 9884009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal neoplasms. A comparison of the fecal occult blood test and endoscopic examination.
    Letsou G; Ballantyne GH; Zdon MJ; Zucker KA; Modlin IM
    Dis Colon Rectum; 1987 Nov; 30(11):839-43. PubMed ID: 3677957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
    O'Leary BA; Olynyk JK; Neville AM; Platell CF
    J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.